Hochheim, Germany

Matthias Braun

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-A Ventis Deutschland Gmbh. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Braun. Retrieved from https://idiyas.com/inventor/matthias-braun-xsplotfl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthias Braun: Innovator in Carbonylation Processes

Introduction: Matthias Braun is a distinguished inventor based in Hochheim, Germany. With expertise in the field of organic chemistry, he has made significant contributions to the process of carbonylation, which is pivotal in the production of various chemical compounds.

Latest Patents: Matthias holds a patent for a groundbreaking method titled "Process for carbonylating phenylalkyl derivatives by means of carbon monoxide." This innovative process enables the preparation of compounds represented by a specific formula, enhancing the efficiency and effectiveness of chemical synthesis in the industry.

Career Highlights: Matthias Braun works at Sanofi-Aventis Deutschland GmbH, a leading company in healthcare and pharmaceutical production. His role involves pioneering research and development efforts that align with the company's mission to advance medical solutions and improve patient care.

Collaborations: Throughout his career, Matthias has collaborated with notable coworkers such as Joachim-Heiner Jendralla and Gerhard Korb. These collaborations have fostered a creative environment that encourages innovation and the pursuit of cutting-edge technology in chemical processes.

Conclusion: Matthias Braun’s contributions to the field of carbonylation reflect his commitment to advancing chemical engineering and synthesis techniques. His innovative approach not only aids his company, Sanofi-Aventis Deutschland GmbH, in staying at the forefront of pharmaceutical development but also contributes to the broader field of organic chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…